| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 0 | 0 | 11 | 14 | 26 | 22 | 23 |
| Expenses | 0 | -0 | 11 | 13 | 25 | 21 | 22 |
| EBITDA | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Operating Profit % | 0 % | 0 % | 2 % | 6 % | 4 % | 5 % | 2 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| EPS in ₹ | 0.09 | 0.52 | 0.79 | 0.28 | 0.22 | 0.22 | 0.24 |
Aayush Wellness
Aayush Wellness
58.49
-3.07
(-4.99%)
Key Fundamentals
Market Cap
299.60 Cr
EPS
0.69
PE Ratio
66.47
Dividend Yield
0.02 %
Industry
Food Products 52 Week High
267.30
52 Week Low
51.62
PB Ratio
34.38
Debt to Equity
0.00
Sector
Packaged Foods Actual
Company News
View All News
Aayush Wellness Limited has welcomed the Government of India's announcement to reduce GST rates on healthcare and wellness products. The integrated healthcare company expects this policy change to make preventive healthcare more affordable and accessible to a larger population segment. The company communicated this development to stock exchanges through a press release.
Aayush Wellness Partners with Healthrashi Nextgen in Joint Venture for Integrated Healthcare Solutions
Sep 22, 2025
Sep 22, 2025Aayush Wellness Limited has entered into a joint venture agreement with Healthrashi Nextgen India Limited to deliver integrated healthcare solutions. Under this collaboration, Aayush Wellness will source medical equipment including AI-enabled health kiosks, mobile clinics, automated diagnostic platforms, and healthcare vending machines at optimized cost from Healthrashi Nextgen. The partnership is part of Aayush Wellness's ₹50 Million Startup Accelerator Program and aims to expand the company's presence in India's $370 billion healthcare market. Aayush Wellness will operate these technologies under its own brand, targeting corporates, banks, residential societies, and educational institutions to provide on-ground health checkups. The agreement is valid for a lifetime period and focuses on addressing healthcare access gaps in semi-urban and rural populations. Managing Director Naveena Kumar stated the collaboration aligns with the company's mission to build a technology-driven wellness ecosystem and deliver affordable preventive care.
Aayush Wellness Limited has incorporated two wholly owned subsidiaries in Maharashtra. AAYUSH LABS PRIVATE LIMITED was incorporated on August 26, 2025, with an authorized share capital of Rs. 25 lakh divided into 2.5 lakh equity shares of Rs. 10 each, focusing on diagnostic and medical activities. AAYUSH VENTURES PRIVATE LIMITED was incorporated on August 27, 2025, with an authorized share capital of Rs. 50 lakh divided into 5 lakh equity shares of Rs. 10 each, focusing on software activities. Both subsidiaries received Certificates of Incorporation from the Central Registration Centre, Ministry of Corporate Affairs. The company fully subscribed to all equity shares of both subsidiaries through cash consideration. These subsidiaries are intended to drive business expansion in diagnostics aggregator and software-related activities respectively.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,289.50 | #1 2,46,168.60 | 84.25 | #1 20,260.40 | -17.45 | #1 3,208 | -17.38 | 73.65 | |
6,083.00 | 1,45,135.20 | 66.78 | 18,169.80 | 6.99 | 2,178 | 3.01 | 60.13 | |
734.20 | 18,399.80 | 94.22 | 2,654.80 | 12.65 | 194 | 1.21 | 44.24 | |
460.90 | 14,959.90 | 44.80 | 2,722.50 | 16.26 | 347 | -13.41 | 48.58 | |
1,999.70 | 13,170.80 | 6.27 | 18,567.10 | 6.06 | 2,199 | 5.53 | 64.89 | |
1,362.60 | 7,841.80 | 60.24 | 1,902.90 | 15.82 | 143 | -12.71 | 59.84 | |
349.50 | 4,238.40 | #1 -1,589.09 | 1,473.60 | 4.74 | 19 | -89.71 | 46.66 | |
1,045.90 | 2,529.70 | 122.35 | 1,660.70 | #1 17.76 | 20 | #1 820.00 | 58.07 | |
8,991.50 | 2,287.70 | 61.47 | 573.00 | 2.65 | 26 | 321.62 | 43.52 | |
203.65 | 2,249.50 | 31.89 | 603.60 | 13.59 | 69 | 5.56 | 35.78 |
Growth Rate
Revenue Growth
9,075.00 %
Net Income Growth
466.67 %
Cash Flow Change
166.67 %
ROE
249.44 %
ROCE
240.32 %
EBITDA Margin (Avg.)
-2,516.72 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2024 | 2025 |
| Total Assets | 5 | 9 |
| Fixed Assets | 0 | 0 |
| Current Assets | 1 | 2 |
| Capital Work in Progress | 0 | 0 |
| Investments | 0 | 0 |
| Other Assets | 5 | 9 |
| Total Liabilities | 5 | 9 |
| Current Liabilities | 0 | 0 |
| Non Current Liabilities | 0 | 0 |
| Total Equity | 5 | 8 |
| Reserve & Surplus | 2 | 3 |
| Share Capital | 3 | 5 |
Cash Flow
| Cash Flow | 2024 | 2025 |
| Net Cash Flow | -1 | 0 |
| Investing Activities | 0 | 0 |
| Operating Activities | -1 | 0 |
| Financing Activities | 0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
| Promoter | 51.28 % | 51.28 % | 32.52 % | 32.52 % | 32.52 % | 32.52 % | 32.52 % | 32.52 % | 27.90 % | 27.90 % | 9.99 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.05 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 26.75 % | 27.90 % | 33.24 % | 33.26 % | 33.35 % | 33.33 % | 33.29 % | 33.24 % | 20.28 % | 23.93 % | 25.99 % | 22.30 % | 20.78 % | 20.73 % | 21.17 % | 28.40 % | 25.18 % | 25.66 % |
| Others | 21.97 % | 20.83 % | 34.24 % | 34.21 % | 34.13 % | 34.14 % | 34.18 % | 34.24 % | 51.82 % | 48.17 % | 64.02 % | 77.70 % | 79.22 % | 79.27 % | 78.83 % | 70.55 % | 74.82 % | 74.34 % |
| No of Share Holders | 0 | 0 | 2,103 | 2,226 | 2,179 | 2,316 | 2,399 | 2,438 | 2,419 | 2,288 | 2,273 | 2,133 | 2,069 | 2,345 | 5,359 | 19,637 | 18,654 | 32,632 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 28 Mar 2024 |  Change Of Name | NA | 28 Mar 2024 | 11.49 | 11.49 |
| 19 Jun 2024 |  Split | 1:10 | 05 Aug 2024 | 18.66 | 18.66 |
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 34.89 | 44.17 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 72.30 | 81.33 |
| 26 Dec 2024 |  Bonus | 1:2 | 26 Dec 2024 | 125.20 | 135.40 |
| 13 Feb 2025 | Quarterly Result Announcement | NA | 13 Feb 2025 | 53.24 | 59.70 |
| 03 Mar 2025 |  Dividend | ₹ 0.01 /share | 03 Mar 2025 | 58.24 | 66.16 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 114.63 | 131.65 |
| 05 Aug 2025 | Dividend | ₹ 0.03 /share | 05 Aug 2025 | 223.25 | 199.70 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 189.75 | 154.65 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 87.72 | 70.41 |
Announcements
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20185 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 04, 2025
Oct 04, 2025Intimation Of Incorporation Of Singapore Wholly Owned SubsidiaryOct 04, 2025
Oct 04, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 24, 2025
Sep 24, 2025Closure of Trading WindowSep 24, 2025
Sep 24, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 22, 2025
Sep 22, 2025Strategic Collaboration With Healthrashi Nextgen India Limited To Deliver Integrated Healthcare SolutionsSep 22, 2025
Sep 22, 2025Intimation Of Record Date For 41St Annual General Meeting Of The CompanySep 08, 2025
Sep 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Sep 05, 2025Reg. 34 (1) Annual Report.Sep 04, 2025
Sep 04, 2025Submission Of Notice Of 41St Annual General Meeting For The FY 2024-25Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sSep 04, 2025
Sep 04, 2025Board Meeting Outcome for Declaration Of Annual General Meeting For The FY 2024-25Sep 04, 2025
Sep 04, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 03, 2025
Sep 03, 2025Board Meeting Outcome for Launch Of Aayush Labs: Redefining Preventive Healthcare Through Digital Diagnostics.Sep 03, 2025
Sep 03, 2025Intimation Of Incorporation Of Wholly Owned SubsidiariesAug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Resignation of Statutory AuditorsAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Aug 13, 2025Outcome Of Board MeetingAug 12, 2025
Aug 12, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2025
Aug 12, 2025Board Meeting Outcome for Outcome Of Board MeetingAug 12, 2025
Aug 12, 2025Outcome Of Board Meeting For The Quarter Ended June 2025Aug 12, 2025
Aug 12, 2025Submission Of Intimation Received From Ms. Pallavi Mittal For Re-Classification Of Shareholding From Promoter Category To Public CategoryAug 07, 2025
Aug 07, 2025Board Meeting Intimation for Declaration Of Unaudited Financial Results For The Quarter Ended June 30 2025Aug 06, 2025
Aug 06, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 30, 2025
Jul 30, 2025Outcome Of Board Meeting For Declaration Of Interim Dividend And Record DateJul 30, 2025
Jul 30, 2025Corporate Action-Board approves DividendJul 30, 2025
Jul 30, 2025Announcement under Regulation 30 (LODR)-Dividend UpdatesJul 30, 2025
Jul 30, 2025Board Meeting Outcome for Outcome Of Board MeetingJul 30, 2025
Jul 30, 2025Board Meeting Intimation for Declaration Of Interim DividendJul 24, 2025
Jul 24, 2025Outcome Of The Board Meeting Held On July 11 2025 For Launching Of Brain Fuel Capsules.Jul 11, 2025
Jul 11, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 11, 2025
Jul 11, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held For Launching Of Brain Fuel Capsules.Jul 11, 2025
Jul 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Jul 10, 2025Outcome Of The Board Meeting Held On July 01 2025.Jul 01, 2025
Jul 01, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 01, 2025
Jul 01, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On July 01 2025.Jul 01, 2025
Jul 01, 2025Closure of Trading WindowJun 24, 2025
Jun 24, 2025Outcome Of The Board Meeting Held On June 20 2025.Jun 20, 2025
Jun 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 20, 2025
Jun 20, 2025Board Meeting Outcome for Outcome Of The Board Meeting Held On June 20 2025.Jun 20, 2025
Jun 20, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 09, 2025
Jun 09, 2025Board Meeting Outcome for Aayush Wellness Limited To Form Wholly Owned Subsidiary In Singapore To Drive Southeast Asia Expansion.Jun 09, 2025
Jun 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 31, 2025
May 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2025
May 30, 2025Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31/03/2025May 30, 2025
May 30, 2025Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended 31/03/2025May 30, 2025
May 30, 2025Technical Indicators
RSI(14)
Neutral 29.64
ATR(14)
Less Volatile 4.34
STOCH(9,6)
Neutral 22.71
STOCH RSI(14)
Neutral 31.80
MACD(12,26)
Bullish 1.38
ADX(14)
Strong Trend 46.00
UO(9)
Bearish 33.91
ROC(12)
Downtrend And Accelerating -12.34
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
